Cytotoxic lymphocyte-mediated immunotherapy

Area of Science:

• Immunology
• Cell Biology
• Molecular Biology

Background:

• Cytotoxic CD8+ T cells and Natural Killer (NK) cells are vital immune components.
• These cells are involved in viral infections, graft rejection, anti-tumor responses, immunoregulation, and autoimmune diseases.
• Their central role and therapeutic potential drive ongoing research.

Purpose of the Study:

• To review current research on cytotoxic lymphocyte function.
• To outline strategies for enhancing anti-tumor activity of these cells.
• To highlight advancements in understanding their mechanisms and therapeutic applications.

Main Methods:

• Molecular biology techniques to characterize recognition structures and cytotoxicity mechanisms.
• In vivo studies to determine the relevance of these mechanisms.
• Development of biological and genetic experimental approaches for immunotherapy.

Main Results:

• Characterization of recognition structures on cytotoxic lymphocytes.
• Definition of two distinct cytotoxicity mechanisms and their in vivo relevance.
• Advancements in adoptive transfer, engineered monoclonal antibodies, and tumor antigen identification.

Conclusions:

• Cytotoxic lymphocytes are key players in various immune responses.
• Molecular and biological approaches are enhancing their therapeutic potential.
• Significant progress has been made in harnessing these cells for anti-tumor therapy.